Muscle Building Peptides Selank 5mg / Vial
Product Details:
Alias: Selanc
CAS: 129954-34-3
Séquence: Thr-Lys-PRO-Arg-PRO-Gly-PRO
MF: C33H57N11O9
MW: 751.9
Pureté: 99%
spécification: 5mg/flacon
Apparence: Poudre lyophilisée blanche
Lieu d'origine: Chine
Standard: USP
Attestation: SGS
Méthode d'analyse: HPLC
La description
Selank or selanc is a synthetic heptapeptide analog of the endogenous tetrapeptide tuftsin, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Selank is sometimes called tuftsin analog 7. Tuftsin was discovered by Victor Najjar in 1969 (Siemion and Kluczyk, 1999), is produced primarily in the spleen, and is a fraction of Immunoglobulin Gamma (IgG). Selank was first synthesized in Russia as part of efforts to find a “superagonist” version of tuftsin, because tuftsin .
The effects of selank can be divided into two broad categories: neurological and immunomodulatory, with the former coming from selank’s effects on BDNF (brain-derived neurotrophic factor) upregulation and enkephalin preservation, and the latter coming from the stimulatory effect of selank on phagocytes, neutrophils, and other immune cells. Selank has shown anxiolytic, nootropic, antidepressant, bacteriocidal, antitumor, and effects in vitro and in vivo as well as promise for various chronic and acute disease states. While selank’s actions may be viewed as belonging to two categories, the emerging field of “neuroimmunology” provides new explanations for the effects of immunomodulators on memory and behavior.
Applications:
Selank is closely related to Semax, a hexapeptide previously invented by the same institute. Some consider Selank to be a more efficient alternative to Semax – a drug currently approved for use in Russia and Ukraine. Both Selank and Semax seem to be less known in the western countries, due to the conflict of interest and subsequently lack of marketing efforts from the “big pharma” industry.
Directeur commercial